UK Renal Registry, Southmead Hospital, Bristol, UK.
Nephron Clin Pract. 2011;119 Suppl 2:c239-48. doi: 10.1159/000331781. Epub 2011 Aug 26.
Renal transplantation is recognised as being the optimal treatment modality for many patients with end stage renal disease. This analysis aimed to explore the equity of access to renal transplantation in the UK.
Transplant activity and waiting list data were obtained from NHS Blood and Transplant, demographic and laboratory data were obtained from the UK Renal Registry. All incident RRT patients starting treatment between 1st January 2004 and 31st December 2006 from 65 renal centres were considered for inclusion. The cohort was followed until 31st December 2008 (or until transplantation or death, whichever was earliest).
Age, ethnicity and primary renal diagnosis were associated with both accessing the kidney transplant waiting list and receiving an organ. A patient starting dialysis in a non-transplanting renal centre was less likely to be registered for transplantation (OR 0.90, 95% CI 0.82-0.99) or receive a transplant from a donor after cardiac death or a living kidney donor (OR 0.69, 95% CI 0.60-0.79) compared with patients cared for in transplanting renal centres. Once registered for kidney transplantation, patients in both transplanting and nontransplanting renal centres had an equal chance of receiving a transplant from a donor after brain stem death (OR 0.92, 95% CI 0.78-1.08).
There is wide variation in access to kidney transplantation between UK renal centres which cannot be explained by differences in case mix.
肾移植被认为是许多终末期肾病患者的最佳治疗方法。本分析旨在探讨英国肾移植的公平性。
从 NHS 血液与移植中心获取移植活动和等待名单数据,从英国肾脏登记处获取人口统计学和实验室数据。考虑纳入所有在 2004 年 1 月 1 日至 2006 年 12 月 31 日期间从 65 个肾脏中心开始治疗的新开始接受 RRT 的患者。该队列一直随访到 2008 年 12 月 31 日(或直至移植或死亡,以先发生者为准)。
年龄、种族和原发性肾脏诊断与进入肾移植等待名单和接受器官都有关。在非移植肾脏中心开始透析的患者,登记接受移植的可能性较低(OR 0.90,95%CI 0.82-0.99),或接受心脏死亡或活体供肾者供肾移植的可能性也较低(OR 0.69,95%CI 0.60-0.79)与在移植肾脏中心接受治疗的患者相比。一旦登记接受肾移植,无论是在移植肾脏中心还是非移植肾脏中心的患者,从脑死亡供者接受移植的机会均等(OR 0.92,95%CI 0.78-1.08)。
英国肾脏中心之间接受肾移植的机会存在广泛差异,这种差异不能用病例组合的差异来解释。